EX-99.1 2 lifeway_ex9901.htm PRESS RELEASE DATED NOVEMBR 12, 2026

Exhibit 99.1

 

Lifeway Foods® Reports Record High Quarterly Net Sales, Extends Kefir Category Leadership in Third Quarter 2026

 

28th consecutive quarter of year-over-year net sales growth; year-to-date 2026 net sales up 25.8%

 

 

Morton Grove, IL — November 12, 2026 — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the third quarter ended September 30, 2026.

 

“Lifeway delivered another record breaking quarter with net sales of $67.8 million, extending our streak of topline growth to 28 consecutive quarters,” said Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods. “The consistent, volume-led growth we are seeing for our authentic Lifeway Kefir and Lifeway Farmer Cheese is extraordinary, reflecting the deep trust we have established with our growing consumer base and the ongoing commitment of our retailer partners. Our performance also reflects the rising demand for fermented dairy, as consumers increasingly seek functional, high quality-protein offerings and retailers identify ways to dedicate more shelf space to products like ours. With 7 years of uninterrupted growth and decades spent building this category, Lifeway is uniquely positioned to meet the moment and capitalize on this demand.”

 

Ms. Smolyansky continued, “Profitability this quarter continued to reflect an elevated input cost environment, and while we expect the cost pressure to persist in the fourth quarter, our outlook for 2027 has not changed. We expect the planned price increases  across our portfolio to take effect with distributors and retailers on a rolling basis through the end of the year and into the first quarter of 2027. With our pricing actions and the productivity gains we anticipate from our capacity investments, we expect gross margin expansion and improved profitability in 2027.   The scale-up of our Waukesha facility, scheduled for completion in early 2027, will eliminate capacity challenges we have encountered and allow us to serve the massive level of demand in front of us. We are well on pace to shatter our annual net sales record in 2026, and look forward to extending our category leadership and building on this momentum as we look ahead to 2027.”

 

Third Quarter 2026 Highlights

 

·Net Sales: $67.8 million, the highest quarterly net sales in Company history, up 18.6% year-over-year, primarily driven by higher volumes of the Company’s branded drinkable kefir.
·Gross Profit Margin: 18.0% , compared to 28.7% in the prior-year period, primarily reflecting elevated input costs including milk, resin-based packaging, ingredients, and transportation costs.
·Selling, general and administrative expenses were 16.2% of net sales, compared to 19.6% last year, reflecting continued investment in marketing and brand awareness.
·Net Income: $0.3 million, or $0.02 per basic and diluted common share, compared to net income of $3.5 million, or $0.23 per basic and diluted common share, in the prior-year period.

 

 

 

 

 

 1 

 

 

Year-to-Date 2026 Highlights

 

·Net Sales: $197.7 million, up 25.8% year-over-year.
·Gross Profit Margin: 21.5%, compared to 27.3% in the prior-year period.
·Selling, general and administrative expenses were 17.2% of net sales, compared to 19.1% last year,
·Net Income: $5.1 million, or $0.33 per basic and diluted common share, compared to net income of $11.3 million, or $0.75 per basic and $0.74 per diluted common share, in the prior-year period.

 

Historic Growth Record

 

·28 consecutive quarters of year-over-year net sales growth, reflecting seven years of uninterrupted quarterly growth.
·Four consecutive years of record annual net sales from 2022 through 2025, increasing from $141.6 million to $212.5 million – a cumulative increase of 50.1%.
·Year-to-date net sales equaled approximately 93% of full-year 2025 net sales, with the Company well on pace to set a record high in annual net sales in 2026, far exceeding the high-bar set in 2025.

 

Industry Recognition

 

In October, Lifeway was named to Fortune’s 2026 list of the 100 Fastest-Growing Companies, ranking No. 45, reflecting the Company’s sustained, volume-led growth and the strength of consumer demand for kefir and other cultured dairy products. This inclusion places Lifeway among an elite group of publicly traded companies that have delivered notably strong financial performance. This follows the induction of President and Chief Executive Officer Julie Smolyansky into the Specialty Food Association Hall of Fame this summer, in recognition of her leadership in transforming kefir from a niche product into a mainstream functional-food category.

 

Conference Call and Webcast

A live conference call and Q&A session with management discussing these results with additional comments and details will be made available through the “Investor Relations” section of the Company’s website at https://lifewaykefir.com/webinars-reports/ at 4:30 p.m. ET on November 12, 2026. Those interested in participating in the live call can dial 1-877-407-9716 or 1-201-493-6779. The webcast will be archived and available for replay.

 

About Lifeway Foods, Inc.

Lifeway Foods, Inc. is the brand that introduced kefir to generations of American consumers. For 40 years, Lifeway has defined authentic, real kefir in the U.S. market while building the expertise, consumer trust and scale that support its category leadership. The Company has been recognized as one of America’s Growth Leaders by TIME, as Dairy Foods’ Processor of the Year 2025, as one of Forbes’ Best Small Companies and on Inc.’s 2025 Best in Business list in the Best Challenger Brands category. In addition to its drinkable kefir portfolio, Lifeway produces Farmer Cheese – a 40-year legacy line now expanding to mass retail – Kefir Butter, Muscle Mates™, a variety of cheeses and ProBugs® for kids. Lifeway products are sold across the United States, Mexico, the United Arab Emirates, Central America and the Caribbean. Learn more at lifewayfoods.com

 

 

 

 2 

 

 

Forward-Looking Statements

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, unaudited estimated net sales. These statements use words, and variations of words, such as "anticipate," "plan," "project," "estimate," "potential," "forecast," "will," "continue," "future," "increase," "believe," "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Lifeway expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.

 

 

Derek Miller

Vice President of Communications, Lifeway Foods
Email: [email protected] 

 

General inquiries:

Lifeway Foods, Inc.

Phone: 847-967-1010

Email: [email protected]

 

 

 

 

 

 

 3 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Unaudited Consolidated Balance Sheets

September 30, 2026 and December 31, 2025

(In thousands)

 

         
   September 30,   December 31, 
   2026   2025 
   (Unaudited)     
Current assets          
Cash and cash equivalents  $6,975   $5,571 
Accounts receivable, net of allowance for credit losses and discounts & allowances of $2,900 and $1,730 at September 30, 2026 and December 31, 2025, respectively   22,353    16,643 
Inventories, net   13,594    11,890 
Prepaid expenses and other current assets   2,470    2,627 
Refundable income taxes   636    325 
Total current assets   46,028    37,056 
           
Property, plant and equipment, net   67,393    48,282 
Operating lease right-of-use asset   504    465 
Goodwill   11,704    11,704 
Intangible assets, net   5,413    5,818 
Other assets   1,629    2,285 
Total assets  $132,671   $105,610 
           
Current liabilities          
Accounts payable  $12,739   $11,008 
Accrued expenses   6,363    5,413 
Accrued income taxes   716    218 
Total current liabilities   19,818    16,639 
           
Line of credit   11,950    – 
Note payable   12,032    – 
Operating lease liabilities   370    360 
Deferred income taxes, net   2,792    2,792 
Other long-term liabilities   251    – 
Total liabilities   47,213    19,791 
           
Commitments and contingencies (Note 9)   –    – 
           
Stockholders’ equity          
Preferred stock, no par value; 2,500 shares authorized; none issued   –    – 
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,108 and 15,232 outstanding at September 30, 2026 and December 31, 2025, respectively   6,509    6,509 
Treasury stock, at cost   (17,194)   (13,214)
Paid-in capital   2,401    3,843 
Retained earnings   93,742    88,681 
Total stockholders’ equity   85,458    85,819 
           
Total liabilities and stockholders’ equity  $132,671   $105,610 

 

 

 

 

 4 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For the three and nine months ended September 30, 2026 and 2025

(Unaudited)

(In thousands, except per share data)

 

                 
  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2026   2025   2026   2025 
                 
Net sales  $67,797   $57,143   $197,702   $157,135 
                     
Cost of goods sold   54,599    39,821    152,199    111,744 
Depreciation expense   1,034    914    2,962    2,548 
Total cost of goods sold   55,633    40,735    155,161    114,292 
                     
Gross profit   12,164    16,408    42,541    42,843 
                     
Selling expense   6,434    5,047    20,256    14,463 
General and administrative expense   4,510    6,186    13,870    15,566 
Amortization expense   135    135    405    405 
Total operating expenses   11,079    11,368    34,531    30,434 
                     
Income from operations   1,085    5,040    8,010    12,409 
                     
Other income (expense):                    
Interest expense   (340)   (21)   (623)   (56)
Fair Value Loss on investments   –    –    –    (20)
Gain on sale of investments   –    –    –    3,407 
Other income (expense), net   20    73    42    229 
Total other income (expense)   (320)   52    (581)   3,560 
                     
Income before provision for income taxes   765    5,092    7,429    15,969 
                     
Provision for income taxes   505    1,563    2,368    4,651 
                     
Net income  $260   $3,529   $5,061   $11,318 
                     
Net earnings per common share:                    
Basic  $0.02   $0.23   $0.33   $0.75 
Diluted  $0.02   $0.23   $0.33   $0.74 
                     
Weighted average common shares outstanding:                    
Basic   15,107    15,229    15,174    15,190 
Diluted   15,253    15,422    15,314    15,381 

 

 

 

 

 5 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

         
   Nine months ended September 30, 
   2026   2025 
Cash flows from operating activities:          
Net income  $5,061   $11,318 
Adjustments to reconcile net income to operating cash flow:          
Depreciation and amortization   3,367    2,953 
Stock-based compensation   1,708    1,466 
Non-cash interest expense   16    14 
Bad debt expense   87    – 
Gain on sale of equipment   (17)   (115)
Gain on sale of investments   –    (3,407)
Fair value loss on investment   –    20 
(Increase) decrease in operating assets:          
Accounts receivable   (5,797)   (1,997)
Inventories   (1,704)   (2,378)
Prepaid expenses and other current assets   354    123 
Refundable income taxes   (311)   497 
Increase (decrease) in operating liabilities:          
Accounts payable   2,413    3,330 
Accrued expenses   (988)   (1,143)
Accrued income taxes   497    – 
Other long-term liabilities   251    – 
Net cash provided by operating activities   4,937    10,681 
           
Cash flows from investing activities:          
Purchases of property and equipment   (22,757)   (9,675)
Proceeds from sale of equipment   433    115 
Proceeds from sale of investments   –    5,206 
Net cash (used in) provided by investing activities   (22,324)   (4,354)
           
Cash flows from financing activities:          
Purchase of treasury stock   (4,937)   – 
Borrowings under line of credit   25,000    – 
Repayments under line of credit   (13,000)   – 
Proceeds from note payable   12,032    – 
Payment of deferred financing costs   (21)   (65)
Equity award settled in cash   (283)   – 
Net cash provided by (used in) financing activities   18,791    (65)
           
Net increase in cash and cash equivalents   1,404    6,262 
           
Cash and cash equivalents at the beginning of the period   5,571    16,728 
           
Cash and cash equivalents at the end of the period  $6,975   $22,990 
           
Supplemental cash flow information:          
Cash paid for income taxes, net of (refunds)  $2,181   $4,154 
Cash paid for interest  $511   $42 
           
Non-cash investing activities          
Accrued purchase of property and equipment  $93   $3,875 
Right-of-use assets obtained in exchange for lease obligations  $135   $293 

 

 

 

 6